Early detection remains one of the biggest challenges in cancer care, particularly for ovarian cancer, where symptoms can be difficult to r...
The development of cannabinoid and psychedelic medicines is entering a more evidence-driven phase, with clinical validation, safety, regulatory a...
As AI and digital technologies increasingly influence pharmaceutical development, CDMOs are taking on a broader role in helping sponsors im...
As breast imaging continues to evolve toward more quantitative and patient-centred approaches, QT Imaging is developing a three-dimensional ultraso...
Pfizer Inc. (NYSE: PFE) and Valneva SE (Nasdaq: VALN; Euronext Paris: VLA) announced that the European Medicines Agency (EMA) has validated the Mar...
Drug development is inherently uncertain, with scientific discoveries, manufacturing challenges, regulatory expectations and commercial priorities ...
Bone Biologics is developing a targeted approach to bone regeneration through its proprietary NELL-1 platform, designed to address the li...
The recent Bundibugyo Ebola virus outbreak underscored the limitations of relying solely on highly targeted diagnostics, highlighting the need for more ada...
Enterprise-grade Signals software with guided onboarding positioned specifically for early-stage biotechs Science-first setup with ready-to-use...
ASC48 is a potentially first-in-class oral small molecule GIPR agonist. - ASC48 demonstrated an EC50 of 1 pM in the hGIPR cAMP activation assay, exhibit...
As artificial intelligence and advanced technologies transform the pharmaceutical industry, leaders face the challenge of harnessing innovation wit...
AI hasn’t taken over clinical trials. It’s taken over the parts of clinical trials nobody wanted to do manually in the first place. Clinicians ...
Since people rely on this type of care for practically everything, be it preventing an illness or managing one, a strong workforce is needed. Now, t...
In 2024 alone, the FDA approved 50 novel therapies, supported by about 31,000 participants in pivotal trials. This is a powerful base of evidence, but it i...
© 2026 Biopharma Boardroom. All Rights Reserved.
